180 Life Sciences Corp (NASDAQ:ATNF)’s traded shares stood at 16.12 million during the last session. At the close of trading, the stock’s price was $2.90, to imply an increase of 55.08% or $1.03 in intraday trading. The ATNF share’s 52-week high remains $17.75, putting it -512.07% down since that peak but still an impressive 60.0% since price per share fell to its 52-week low of $1.16. The company has a valuation of $8.89M, with an average of 1.76 million shares in intraday trading volume over the past 10 days and average of 2.01 million shares over the past 3 months.

180 Life Sciences Corp (NASDAQ:ATNF) trade information

After registering a 55.08% upside in the last session, 180 Life Sciences Corp (ATNF) has traded red over the past five days. The 5-day price performance for the stock is 47.80%, and 19.56% over 30 days. With these gigs, the year-to-date price performance is -33.69%. Short interest in 180 Life Sciences Corp (NASDAQ:ATNF) saw shorts transact 0.14 million shares and set a 0.03 days time to cover.

ATNF Dividends

180 Life Sciences Corp has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

180 Life Sciences Corp (NASDAQ:ATNF)’s Major holders

180 Life Sciences Corp insiders hold 4.34% of total outstanding shares, with institutional holders owning 3.45% of the shares at 3.61% float percentage. In total, 3.45% institutions holds shares in the company.